HEADER PEPTIDE BINDING PROTEIN 19-APR-20 6YR7 TITLE 14-3-3 SIGMA IN COMPLEX WITH HDMX-342+367 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: 14-3-3 PROTEIN SIGMA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: EPITHELIAL CELL MARKER PROTEIN 1,STRATIFIN; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: PROTEIN MDM4; COMPND 8 CHAIN: Q, C; COMPND 9 SYNONYM: DOUBLE MINUTE 4 PROTEIN,MDM2-LIKE P53-BINDING PROTEIN, COMPND 10 PROTEIN MDMX,P53-BINDING PROTEIN MDM4; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SFN, HME1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606 KEYWDS BIVALENT BINDING MODE, 1433, PEPTIDE BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.WOLTER,S.SRDANOVIC,S.WARRINER,A.WILSON,C.OTTMANN REVDAT 3 24-JAN-24 6YR7 1 REMARK REVDAT 2 13-APR-22 6YR7 1 JRNL REMARK REVDAT 1 03-NOV-21 6YR7 0 JRNL AUTH S.SRDANOVIC,M.WOLTER,C.H.TRINH,C.OTTMANN,S.L.WARRINER, JRNL AUTH 2 A.J.WILSON JRNL TITL UNDERSTANDING THE INTERACTION OF 14-3-3 PROTEINS WITH HDMX JRNL TITL 2 AND HDM2: A STRUCTURAL AND BIOPHYSICAL STUDY. JRNL REF FEBS J. 2022 JRNL REFN ISSN 1742-464X JRNL PMID 35286747 JRNL DOI 10.1111/FEBS.16433 REMARK 2 REMARK 2 RESOLUTION. 2.11 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.12_2829 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.11 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 56.26 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 42044 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 4122 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 56.2640 - 6.4634 0.99 2676 149 0.1708 0.1676 REMARK 3 2 6.4634 - 5.1313 1.00 2746 136 0.1900 0.2705 REMARK 3 3 5.1313 - 4.4830 1.00 2688 125 0.1511 0.1858 REMARK 3 4 4.4830 - 4.0733 1.00 2745 139 0.1568 0.1438 REMARK 3 5 4.0733 - 3.7814 1.00 2698 140 0.1627 0.2540 REMARK 3 6 3.7814 - 3.5585 1.00 2693 136 0.1902 0.2445 REMARK 3 7 3.5585 - 3.3803 1.00 2725 142 0.2006 0.2339 REMARK 3 8 3.3803 - 3.2331 1.00 2705 150 0.2168 0.2477 REMARK 3 9 3.2331 - 3.1087 0.99 2665 152 0.2340 0.2934 REMARK 3 10 3.1087 - 3.0014 1.00 2703 149 0.2311 0.2437 REMARK 3 11 3.0014 - 2.9076 1.00 2752 140 0.2354 0.2533 REMARK 3 12 2.9076 - 2.8245 1.00 2668 149 0.2366 0.2408 REMARK 3 13 2.8245 - 2.7501 1.00 2739 130 0.2437 0.2783 REMARK 3 14 2.7501 - 2.6830 1.00 2663 140 0.2507 0.3371 REMARK 3 15 2.6830 - 2.6220 1.00 2723 175 0.2464 0.2902 REMARK 3 16 2.6220 - 2.5662 1.00 2759 120 0.2506 0.3136 REMARK 3 17 2.5662 - 2.5149 1.00 2691 126 0.2555 0.3276 REMARK 3 18 2.5149 - 2.4674 1.00 2702 166 0.2680 0.2858 REMARK 3 19 2.4674 - 2.4234 1.00 2669 123 0.2581 0.2867 REMARK 3 20 2.4234 - 2.3823 1.00 2757 130 0.2623 0.2984 REMARK 3 21 2.3823 - 2.3439 1.00 2697 131 0.2666 0.3254 REMARK 3 22 2.3439 - 2.3078 0.99 2697 141 0.2672 0.2890 REMARK 3 23 2.3078 - 2.2739 1.00 2683 152 0.2948 0.3100 REMARK 3 24 2.2739 - 2.2418 0.99 2746 149 0.4049 0.4677 REMARK 3 25 2.2418 - 2.2115 1.00 2620 152 0.3468 0.3873 REMARK 3 26 2.2115 - 2.1828 0.99 2629 161 0.3302 0.3289 REMARK 3 27 2.1828 - 2.1555 1.00 2745 167 0.3254 0.3260 REMARK 3 28 2.1555 - 2.1296 1.00 2708 125 0.3351 0.3631 REMARK 3 29 2.1296 - 2.1050 0.83 2246 127 0.3725 0.3780 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.640 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 40.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 3718 REMARK 3 ANGLE : 0.492 5022 REMARK 3 CHIRALITY : 0.031 571 REMARK 3 PLANARITY : 0.002 645 REMARK 3 DIHEDRAL : 13.593 2279 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6YR7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-APR-20. REMARK 100 THE DEPOSITION ID IS D_1292107840. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-MAR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 XE 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42044 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 65.110 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.04500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.17 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.46000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3LW1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM CITRATE TRIBASIC DIHYDRATE, REMARK 280 PEG3350, BIS-TRIS PROPANE PH8, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 66.55300 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.10650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 66.55300 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.10650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4330 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22360 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, Q, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -4 REMARK 465 GLU A 72 REMARK 465 GLY A 73 REMARK 465 SER A 74 REMARK 465 GLU A 75 REMARK 465 GLU A 76 REMARK 465 GLY B -4 REMARK 465 GLU B 72 REMARK 465 GLY B 73 REMARK 465 SER B 74 REMARK 465 GLU B 75 REMARK 465 GLU B 76 REMARK 465 SER Q 439 REMARK 465 LYS Q 440 REMARK 465 LEU Q 441 REMARK 465 THR Q 442 REMARK 465 THR Q 451 REMARK 465 ALA Q 452 REMARK 465 ILE Q 453 REMARK 465 PRO Q 454 REMARK 465 GLU Q 455 REMARK 465 LYS Q 456 REMARK 465 GLU Q 457 REMARK 465 ASN Q 458 REMARK 465 GLU Q 459 REMARK 465 GLY Q 460 REMARK 465 ASN Q 461 REMARK 465 ASP Q 462 REMARK 465 VAL Q 463 REMARK 465 PRO Q 464 REMARK 465 ASP Q 465 REMARK 465 CYS Q 466 REMARK 465 ARG Q 467 REMARK 465 ARG Q 468 REMARK 465 THR Q 469 REMARK 465 ILE Q 470 REMARK 465 SEP Q 471 REMARK 465 ALA Q 472 REMARK 465 PRO Q 473 REMARK 465 VAL Q 474 REMARK 465 VAL Q 475 REMARK 465 ARG Q 476 REMARK 465 PRO Q 477 REMARK 465 LYS Q 478 REMARK 465 SER C 439 REMARK 465 LYS C 440 REMARK 465 LEU C 441 REMARK 465 THR C 442 REMARK 465 THR C 451 REMARK 465 ALA C 452 REMARK 465 ILE C 453 REMARK 465 PRO C 454 REMARK 465 GLU C 455 REMARK 465 LYS C 456 REMARK 465 GLU C 457 REMARK 465 ASN C 458 REMARK 465 GLU C 459 REMARK 465 GLY C 460 REMARK 465 ASN C 461 REMARK 465 ASP C 462 REMARK 465 VAL C 463 REMARK 465 PRO C 464 REMARK 465 ASP C 465 REMARK 465 CYS C 466 REMARK 465 ARG C 467 REMARK 465 ARG C 468 REMARK 465 THR C 469 REMARK 465 ILE C 470 REMARK 465 SEP C 471 REMARK 465 ALA C 472 REMARK 465 PRO C 473 REMARK 465 VAL C 474 REMARK 465 VAL C 475 REMARK 465 ARG C 476 REMARK 465 PRO C 477 REMARK 465 LYS C 478 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 20 CG CD OE1 OE2 REMARK 470 LYS A 49 CG CD CE NZ REMARK 470 GLN A 67 CG CD OE1 NE2 REMARK 470 LYS A 68 CG CD CE NZ REMARK 470 ASN A 70 CG OD1 ND2 REMARK 470 GLU A 71 CG CD OE1 OE2 REMARK 470 LYS A 77 CG CD CE NZ REMARK 470 GLU A 110 CG CD OE1 OE2 REMARK 470 ASP A 138 CG OD1 OD2 REMARK 470 LYS A 141 CG CD CE NZ REMARK 470 LYS A 195 CG CD CE NZ REMARK 470 ASP A 204 CG OD1 OD2 REMARK 470 GLU A 210 CG CD OE1 OE2 REMARK 470 LYS A 214 CG CD CE NZ REMARK 470 GLN B 67 CG CD OE1 NE2 REMARK 470 LYS B 68 CG CD CE NZ REMARK 470 SER B 69 OG REMARK 470 ASN B 70 CG OD1 ND2 REMARK 470 GLU B 71 CG CD OE1 OE2 REMARK 470 LYS B 77 CG CD CE NZ REMARK 470 LYS B 87 CG CD CE NZ REMARK 470 GLU B 110 CG CD OE1 OE2 REMARK 470 LYS B 141 CG CD CE NZ REMARK 470 LYS B 160 CG CD CE NZ REMARK 470 LYS B 195 CG CD CE NZ REMARK 470 GLU B 210 CG CD OE1 OE2 REMARK 470 ASP B 211 CG OD1 OD2 REMARK 470 TYR B 213 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 214 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 369 O HOH B 379 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 18 75.78 -108.65 REMARK 500 HIS A 106 -38.86 -130.34 REMARK 500 THR A 136 -59.98 -141.54 REMARK 500 ARG B 18 77.05 -106.04 REMARK 500 HIS B 106 -39.09 -136.47 REMARK 500 THR B 136 -53.73 -134.60 REMARK 500 SEP C 446 -167.41 -113.08 REMARK 500 ASP C 449 43.58 -82.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue B3P A 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6YR5 RELATED DB: PDB REMARK 900 HDMX-367 PEPTIDE REMARK 900 RELATED ID: 6YR6 RELATED DB: PDB REMARK 900 HDM2-186 PEPTIDE DBREF 6YR7 A 1 231 UNP P31947 1433S_HUMAN 1 231 DBREF 6YR7 B 1 231 UNP P31947 1433S_HUMAN 1 231 DBREF 6YR7 Q 439 478 UNP O15151 MDM4_HUMAN 335 374 DBREF 6YR7 C 439 478 UNP O15151 MDM4_HUMAN 335 374 SEQADV 6YR7 GLY A -4 UNP P31947 EXPRESSION TAG SEQADV 6YR7 ALA A -3 UNP P31947 EXPRESSION TAG SEQADV 6YR7 MET A -2 UNP P31947 EXPRESSION TAG SEQADV 6YR7 GLY A -1 UNP P31947 EXPRESSION TAG SEQADV 6YR7 SER A 0 UNP P31947 EXPRESSION TAG SEQADV 6YR7 GLY B -4 UNP P31947 EXPRESSION TAG SEQADV 6YR7 ALA B -3 UNP P31947 EXPRESSION TAG SEQADV 6YR7 MET B -2 UNP P31947 EXPRESSION TAG SEQADV 6YR7 GLY B -1 UNP P31947 EXPRESSION TAG SEQADV 6YR7 SER B 0 UNP P31947 EXPRESSION TAG SEQRES 1 A 236 GLY ALA MET GLY SER MET GLU ARG ALA SER LEU ILE GLN SEQRES 2 A 236 LYS ALA LYS LEU ALA GLU GLN ALA GLU ARG TYR GLU ASP SEQRES 3 A 236 MET ALA ALA PHE MET LYS GLY ALA VAL GLU LYS GLY GLU SEQRES 4 A 236 GLU LEU SER CYS GLU GLU ARG ASN LEU LEU SER VAL ALA SEQRES 5 A 236 TYR LYS ASN VAL VAL GLY GLY GLN ARG ALA ALA TRP ARG SEQRES 6 A 236 VAL LEU SER SER ILE GLU GLN LYS SER ASN GLU GLU GLY SEQRES 7 A 236 SER GLU GLU LYS GLY PRO GLU VAL ARG GLU TYR ARG GLU SEQRES 8 A 236 LYS VAL GLU THR GLU LEU GLN GLY VAL CYS ASP THR VAL SEQRES 9 A 236 LEU GLY LEU LEU ASP SER HIS LEU ILE LYS GLU ALA GLY SEQRES 10 A 236 ASP ALA GLU SER ARG VAL PHE TYR LEU LYS MET LYS GLY SEQRES 11 A 236 ASP TYR TYR ARG TYR LEU ALA GLU VAL ALA THR GLY ASP SEQRES 12 A 236 ASP LYS LYS ARG ILE ILE ASP SER ALA ARG SER ALA TYR SEQRES 13 A 236 GLN GLU ALA MET ASP ILE SER LYS LYS GLU MET PRO PRO SEQRES 14 A 236 THR ASN PRO ILE ARG LEU GLY LEU ALA LEU ASN PHE SER SEQRES 15 A 236 VAL PHE HIS TYR GLU ILE ALA ASN SER PRO GLU GLU ALA SEQRES 16 A 236 ILE SER LEU ALA LYS THR THR PHE ASP GLU ALA MET ALA SEQRES 17 A 236 ASP LEU HIS THR LEU SER GLU ASP SER TYR LYS ASP SER SEQRES 18 A 236 THR LEU ILE MET GLN LEU LEU ARG ASP ASN LEU THR LEU SEQRES 19 A 236 TRP THR SEQRES 1 B 236 GLY ALA MET GLY SER MET GLU ARG ALA SER LEU ILE GLN SEQRES 2 B 236 LYS ALA LYS LEU ALA GLU GLN ALA GLU ARG TYR GLU ASP SEQRES 3 B 236 MET ALA ALA PHE MET LYS GLY ALA VAL GLU LYS GLY GLU SEQRES 4 B 236 GLU LEU SER CYS GLU GLU ARG ASN LEU LEU SER VAL ALA SEQRES 5 B 236 TYR LYS ASN VAL VAL GLY GLY GLN ARG ALA ALA TRP ARG SEQRES 6 B 236 VAL LEU SER SER ILE GLU GLN LYS SER ASN GLU GLU GLY SEQRES 7 B 236 SER GLU GLU LYS GLY PRO GLU VAL ARG GLU TYR ARG GLU SEQRES 8 B 236 LYS VAL GLU THR GLU LEU GLN GLY VAL CYS ASP THR VAL SEQRES 9 B 236 LEU GLY LEU LEU ASP SER HIS LEU ILE LYS GLU ALA GLY SEQRES 10 B 236 ASP ALA GLU SER ARG VAL PHE TYR LEU LYS MET LYS GLY SEQRES 11 B 236 ASP TYR TYR ARG TYR LEU ALA GLU VAL ALA THR GLY ASP SEQRES 12 B 236 ASP LYS LYS ARG ILE ILE ASP SER ALA ARG SER ALA TYR SEQRES 13 B 236 GLN GLU ALA MET ASP ILE SER LYS LYS GLU MET PRO PRO SEQRES 14 B 236 THR ASN PRO ILE ARG LEU GLY LEU ALA LEU ASN PHE SER SEQRES 15 B 236 VAL PHE HIS TYR GLU ILE ALA ASN SER PRO GLU GLU ALA SEQRES 16 B 236 ILE SER LEU ALA LYS THR THR PHE ASP GLU ALA MET ALA SEQRES 17 B 236 ASP LEU HIS THR LEU SER GLU ASP SER TYR LYS ASP SER SEQRES 18 B 236 THR LEU ILE MET GLN LEU LEU ARG ASP ASN LEU THR LEU SEQRES 19 B 236 TRP THR SEQRES 1 Q 40 SER LYS LEU THR HIS SER LEU SEP THR SER ASP ILE THR SEQRES 2 Q 40 ALA ILE PRO GLU LYS GLU ASN GLU GLY ASN ASP VAL PRO SEQRES 3 Q 40 ASP CYS ARG ARG THR ILE SEP ALA PRO VAL VAL ARG PRO SEQRES 4 Q 40 LYS SEQRES 1 C 40 SER LYS LEU THR HIS SER LEU SEP THR SER ASP ILE THR SEQRES 2 C 40 ALA ILE PRO GLU LYS GLU ASN GLU GLY ASN ASP VAL PRO SEQRES 3 C 40 ASP CYS ARG ARG THR ILE SEP ALA PRO VAL VAL ARG PRO SEQRES 4 C 40 LYS MODRES 6YR7 SEP Q 446 SER MODIFIED RESIDUE MODRES 6YR7 SEP C 446 SER MODIFIED RESIDUE HET SEP Q 446 13 HET SEP C 446 13 HET B3P A 301 45 HETNAM SEP PHOSPHOSERINE HETNAM B3P 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)- HETNAM 2 B3P PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL HETSYN SEP PHOSPHONOSERINE FORMUL 3 SEP 2(C3 H8 N O6 P) FORMUL 5 B3P C11 H26 N2 O6 FORMUL 6 HOH *179(H2 O) HELIX 1 AA1 GLU A 2 ALA A 16 1 15 HELIX 2 AA2 ARG A 18 GLU A 31 1 14 HELIX 3 AA3 SER A 37 LYS A 68 1 32 HELIX 4 AA4 PRO A 79 HIS A 106 1 28 HELIX 5 AA5 ASP A 113 GLU A 133 1 21 HELIX 6 AA6 GLY A 137 MET A 162 1 26 HELIX 7 AA7 ASN A 166 ILE A 183 1 18 HELIX 8 AA8 SER A 186 ALA A 203 1 18 HELIX 9 AA9 ASP A 204 LEU A 208 5 5 HELIX 10 AB1 SER A 209 THR A 231 1 23 HELIX 11 AB2 GLU B 2 ALA B 16 1 15 HELIX 12 AB3 ARG B 18 GLU B 31 1 14 HELIX 13 AB4 SER B 37 GLU B 71 1 35 HELIX 14 AB5 PRO B 79 HIS B 106 1 28 HELIX 15 AB6 ASP B 113 ALA B 135 1 23 HELIX 16 AB7 GLY B 137 MET B 162 1 26 HELIX 17 AB8 ASN B 166 ILE B 183 1 18 HELIX 18 AB9 SER B 186 ALA B 203 1 18 HELIX 19 AC1 ASP B 204 LEU B 208 5 5 HELIX 20 AC2 SER B 212 THR B 231 1 20 HELIX 21 AC3 SEP Q 446 ILE Q 450 5 5 HELIX 22 AC4 SEP C 446 ILE C 450 5 5 LINK C LEU Q 445 N SEP Q 446 1555 1555 1.33 LINK C SEP Q 446 N THR Q 447 1555 1555 1.33 LINK C LEU C 445 N SEP C 446 1555 1555 1.33 LINK C SEP C 446 N THR C 447 1555 1555 1.33 SITE 1 AC1 10 ASP A 97 ASP A 139 ILE A 143 HOH A 440 SITE 2 AC1 10 HOH A 465 GLN B 93 ASP B 97 ASP B 139 SITE 3 AC1 10 ILE B 143 HOH B 358 CRYST1 133.106 70.213 80.626 90.00 101.97 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007513 0.000000 0.001593 0.00000 SCALE2 0.000000 0.014242 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012679 0.00000